Skip to main content

This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content may only be relevant to HCPs practising in Great Britain (England, Scotland and Wales) according to product availability. This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

  1. Resource
  2. Source: Campus Sanofi
  3. 14 May 2024

Formulary and Service Support

Author: Sanofi

Editorial Team

  

This section has resources that you may require for your formulary submissions and business cases or policy reviews. As well as product information, therapy support resources and treatment guidelines. You can download these materials to better support your decision making.

To unlock content tailored to your locality and receive emails about our products and services

Trurapi ▼ (insulin aspart 100U) Cost Model

Simulate your savings from switching to Trurapi.

Prescribing Information

Product Page

We have a range of cost models available. If you need a more detailed modelling of our basal and rapid acting insulins portfolio, please reach out to one of our representatives.

Dupixent formulary application support pack

Dupixent (dupilumab) Formulary Application Support Pack

This document provides factual and technical information about Dupixent to support you with relevant documentation for local formulary applications.

Prescribing Information (GB)

Prescribing Information (NI)

Product Page

Dupixent Optimisation Model
 

The impact on resource utilisation when using Dupixent in accordance with the SmPC.

Prescribing Information (GB)

Prescribing Information (NI)

Product Page

line gray
Get in Touch with the Health System Solutions Team
MAT-XU-2303054 (v2.0) Date of Preparation: October 2023

MAT-XU-2401933 (v1.0) Date of Preparation: May 2024